Expression of cyclin B1 after induction of senescence and cell death in non-small cell lung carcinoma A549 cells

Folia Histochemica et Cytobiologica

Volumn 50, Issue 1, 2012, Pages 58-67

  Zuryń, Agnieszka ^a   Gagat, Maciej ^a   Grzanka, Aleksandra Antonina ^a   Gackowska, Lidia ^a   Grzanka, Alina ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

A549; Cell death; Cyclin B1; Senescence

Indexed keywords

BETA GALACTOSIDASE; CYCLIN B1; DOXORUBICIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL NUCLEUS; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DRUG EXPOSURE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; NICK END LABELING; PHENOTYPE; PROTEIN EXPRESSION; SENESCENCE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84860289144     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2012.0008     Document Type: Article

References (28)

1. Pines J, Hunter T. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature. 1990;346:760-763.
2. Innocente SA, Abrahamson JLA, Cogswell JP, Lee JM. p53 regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci. 1999;96:2147-2152.
3. Halloway SL, Glotzer M, King RW, Murray AW. Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor. Cell. 1993;73:1393-1402.
4. Sugrue MM, Shin DY, Lee SW, Aaronson SA. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sci. 1997; 94: 9648-9653.
5. Blagosklonny MV. Cell senescence and hypermitogenic arrest. EMBO reports. 2003;4: 358-362.
6. Litwiniec A, Grzanka A, Helmin-Basa A, Gackowska L, Grzanka D. Features of senescence and cell death induced by doxorubicin in A549 cells: organization and level of selected cytoskeletal proteins. J Cancer Res Clin Oncol. 2010;136:717-736.
7. Dimri GP, Lee X, Basile G et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92:9363-9367.
8. Zhang R, Chen W, Adamus PD. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol. 2007;27:2343-2358.
9. Schmitt CA. Cellular senescence and cancer treatment. Biochim Biophys Acta. 2007;1775; 5-20.
10. Roninson IB. Tumor cell senescence in cancer treatment. Cancer Research. 2003;63: 2705-2715.
11. Chen B, Cheng M, Hong DJ, Sun FY, Zhu CQ. Okadaic induced cyclin B1 expression and mitotic catastrophe in rat cortex. Neuroscience Letters. 2006;406:178-182.
12. Park SS, Eom YW, Choi KS. Cdc2 and Cdk2 play critical roles in low dose doxorubicin-induced cell death through mitotic catastrophe but not in high dose doxorubicin-induced apoptosis. Bioch Biophys Res Commun. 2005; 334:1014-1021.
13. Kikuchi I, Nakayama Y, Morinaga T, Fukumoto Yamaguchi N. A decrease in cyclin B1 levels leads to polyploidization in DNA damage-induced senescence. Cell Biol Int. 2010;34:645-653.
14. Waf1/Cip1/Sdi1 levels. Bioch Biophys Acta. 2001;1538:90-97.
15. Dan S, Yamori T. Repression of cyclin B1 expression after treatment with adriamycin, but not cisplatin in human lung cancer A549 cells. Bioch Biophys Res Commun. 2001;280: 861-867.
16. 2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines. Endocr Relat Cancer. 2008;15:623-634.
17. Aaltomaa S, Lipponen P, Ala-Opas M et al. Expression of cyclins A and D and p21 (waf 1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Br J Cancer. 1999;80:2001-2007.
18. Nimeus-Malmström E, Koliadi A, Ahlin C et al. Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort. Int J Cancer. 2010;127:961-967.
19. Kosacka M, Korzeniewska A, Jankowska R. Attempt to assess the prognostic significance of the expression of cyclin B1 in patients operated on for stage I-IIIA non small cell lung cancer-preliminary report. Pol Merk Lek. 2010;164; 117-121.
20. Long H, Gao X, Chen X et al. The significance of cyclin B1 expression in colorectal cancers. Chin J Clin Oncol. 2006;5:399-401.
21. Yasuda M, Takesue F, Inutsuka S et al. Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: an immunohistological study. J Cancer Res Clin Oncol. 2002;128:412-416.
22. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 14-3-3sigma is required to prevent mitotic catastrophy after DNA damage. Nature. 1999;401:616-620.
23. Borgne A, Versteege I, Mahe M et al. Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment. Oncogene. 2006;25:7361-7372.
24. Curry CL, Reed LL, Broude E et al. Notch inhibition in Kaposi's sarcoma tumor cells leads to mitotic catastrophe through nuclear factor-?B signaling. Mol Cancer Ther. 2007;6:1983-1992.
25. Castedo M, Perfettini JL, Roumier T, Kroemer G. Cyclin-dependent kinase-1: linking apoptosis of cell cycle and mitotic catastrophe. Cell Death and Differentiation. 2002;9:1287-1293.
26. Castedo M, Perfettini JL, Roumier T et al. Cell death by mitotic catastrophe: a molecular definition. Oncogene. 2004;23:2825-2837.
27. Porter LA. Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis. Blood. 2003;101:1928-1933.
28. Yuan J, Yan R, Krämer A et al. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene. 2004;23:5843-5852.